As COVID vaccines become more accessible to the public, it’s important to keep in mind the present dangers of other common respiratory illnesses. Transmission of these infections affects everyone, from Baby Boomers to Gen Zers, in various ways that could be fatal for some but a cough to others. Dr. Angela Rasmussen joins us to discuss testing and transmission regarding influenza, respiratory syncytial virus (RSV), and COVID-19.

Hosted by:

Silvia Quevedo, CAE

“Shout out to nose hair … and shout out to physical barriers providing passive immunity”

Angela L. Rasmussen, Ph.D

Angela L. Rasmussen, Ph.D. is a virologist currently affiliated with the Georgetown Center for Global Health Science and Security. In spring 2021, Dr. Rasmussen will also be starting a lab at the Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac), a vaccine research institute at the University of Saskatchewan. Dr. Rasmussen is a member of the Verena Consortium, a multi-disciplinary, international effort to predict and study emerging viral pathogens. Dr. Rasmussen studies the role of the host response in emerging virus pathogenesis, with a particular interest in viruses that are or have the potential to be major threats to global health, such as influenza, dengue, Ebola, MERS-CoV, and SARS-CoV-2.